ICD-10-PCS Billable Code

0G5D4ZZ

Destruction Aortic Body to No Qualifier with No Device, Percutaneous Endoscopic Approach

Procedural Specifications

Clinical Axis Detail Definition
Section0 Medical and Surgical
Body SystemG Endocrine System
Operation5 Destruction
Body PartD Aortic Body
Approach4 Percutaneous Endoscopic
DeviceZ No Device
QualifierZ No Qualifier

Operation Definition

Physical eradication of all or a portion of a body part by the direct use of energy, force, or a destructive agent

Procedure Overview

Destruction procedures in the endocrine system eliminate abnormal or diseased tissue in a gland, such as a thyroid nodule, adrenal mass, or pituitary lesion, using energy sources like radiofrequency, laser, cryotherapy, or chemical agents rather than by cutting the tissue out. The gland or the surrounding tissue is not physically removed from the body; it is destroyed in place and the body absorbs or walls off the treated area over time.

This approach is often chosen for patients who are not good candidates for surgical removal, for smaller lesions that do not require full excision, or when preserving as much of the surrounding healthy gland tissue as possible is a priority, such as with certain benign thyroid nodules treated by ablation.

Anatomy & Axis Detail

Aortic Body

The aortic body is a chemoreceptor cluster located near the arch of the aorta, functioning similarly to the carotid bodies by sensing arterial oxygen, carbon dioxide, and pH to help regulate respiratory drive, though it plays a comparatively smaller role in humans. Destruction in place is an uncommon procedure, generally considered when this tissue is the source of a functioning paraganglioma or when its chemoreceptor reflex activity is thought to contribute to a condition such as resistant hypertension, and is performed using energy or chemical ablation rather than excision. Its location near the great vessels of the mediastinum and close relationship to the vagus nerve and cardiac plexus make precise, image-guided targeting essential to avoid injury to surrounding thoracic structures. Clear anatomic documentation helps distinguish this rare target from the more commonly treated carotid bodies.

Approach: Percutaneous Endoscopic

Percutaneous Endoscopic combines a puncture through skin or mucous membrane with insertion of an endoscope to visualize the procedure internally, as in laparoscopic cholecystectomy. It is distinguished from plain Percutaneous by the presence of scope-guided visualization, and from Via Natural or Artificial Opening Endoscopic by its route being a new puncture rather than an existing orifice or stoma.

Coding & Documentation

The operative note should describe an energy-based or chemical method used to eradicate tissue in place, with no portion of the gland physically excised or taken out. Coders need to identify the exact energy source and gland involved, since the approach and device values depend on whether an image-guided percutaneous probe, an endoscopic device, or an open technique was used.

The most frequent error is coding Destruction when any portion of tissue was actually cut out and removed for pathology, which instead falls under Excision or Resection. When a biopsy is taken from the same lesion before it is ablated, that sampling should be coded separately as an Excision.

Commonly Confused With

ExcisionExcision and Resection are the closest relatives, distinguished by whether tissue is physically taken out of the body rather than destroyed in place.
FragmentationDestruction is also sometimes confused with Fragmentation, which breaks solid material into pieces without necessarily eradicating it, a distinction more relevant to calculi than to soft endocrine tissue.